Design Therapeutics, Inc. Research and Development (R&D) Expenses Growth

Research and Development (R&D) Expenses Growth of DSGN for past 10 years: annual, quarterly and twelve month trailing (TTM) including Research and Development (R&D) Expenses Growth growth rates and interactive chart.


Highlights and Quick Summary

  • Research and Development (R&D) Expenses Growth for the quarter ending June 30, 2023 was 51.08% (a -35.82% decrease compared to previous quarter)
  • Year-over-year quarterly Research and Development (R&D) Expenses Growth decreased by -24.34%
  • Annual Research and Development (R&D) Expenses Growth for 2022 was 96.19% (a -68.86% decrease from previous year)
  • Annual Research and Development (R&D) Expenses Growth for 2021 was 308.88% (a 15.95% increase from previous year)
  • Annual Research and Development (R&D) Expenses Growth for 2020 was 266.38% (a -466.36% decrease from previous year)
  • Twelve month Research and Development (R&D) Expenses Growth ending June 30, 2023 was 70.76% (a -19.03% decrease compared to previous quarter)
  • Twelve month trailing Research and Development (R&D) Expenses Growth decreased by -33.83% year-over-year
Trailing Research and Development (R&D) Expenses Growth for the last four month:
30 Jun '23 31 Mar '23 31 Dec '22 30 Sep '22
70.76% 87.39% 96.19% 106.93%
Visit stockrow.com/DSGN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Research and Development (R&D) Expenses Growth of Design Therapeutics, Inc.

Most recent Research and Development (R&D) Expenses Growthof DSGN including historical data for past 10 years.

Interactive Chart of Research and Development (R&D) Expenses Growth of Design Therapeutics, Inc.

Design Therapeutics, Inc. Research and Development (R&D) Expenses Growth for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2023 51.08% 79.59%
2022 94.29% 67.51% 124.69% 126.04% 96.19%
2021 170.94% 346.13% 373.8% 927.85% 308.88%
2020 -62.67% -77.52% -78.89% -90.27% 266.38%
2019 -72.71%

Business Profile of Design Therapeutics, Inc.

Sector: Healthcare
Industry: Biotechnology